These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 25061619)

  • 21. Review article: the modern diagnosis and management of haemochromatosis.
    Adams PC
    Aliment Pharmacol Ther; 2006 Jun; 23(12):1681-91. PubMed ID: 16817911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemochromatosis case definition: out of focus?
    Adams PC
    Nat Clin Pract Gastroenterol Hepatol; 2006 Apr; 3(4):178-9. PubMed ID: 16582939
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical implications of the hemochromatosis gene.
    Tavill AS
    N Engl J Med; 1999 Sep; 341(10):755-7. PubMed ID: 10471465
    [No Abstract]   [Full Text] [Related]  

  • 24. [Heterozygosis H63D in patients with steatohepatitis and chronic hepatitis C].
    Pulvirenti D; Neri S; Bertino G; Cutuli N; Ignaccolo L; Misseri M; Tsami A; Caruso L
    Clin Ter; 2006; 157(6):485-8. PubMed ID: 17228846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A population-based study of the clinical expression of the hemochromatosis gene.
    Olynyk JK; Cullen DJ; Aquilia S; Rossi E; Summerville L; Powell LW
    N Engl J Med; 1999 Sep; 341(10):718-24. PubMed ID: 10471457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HFE, iron homeostasis and genetic hemochromatosis.
    Cazzola M
    Haematologica; 2000 Apr; 85(4):338-9. PubMed ID: 10756355
    [No Abstract]   [Full Text] [Related]  

  • 27. Mixture models of serum iron measures in population screening for hemochromatosis and iron overload.
    McLaren CE; Li KT; McLaren GD; Gordeuk VR; Snively BM; Reboussin DM; Barton JC; Acton RT; Dawkins FW; Harris EL; Eckfeldt JH; Moses GC; Adams PC
    Transl Res; 2006 Oct; 148(4):196-206. PubMed ID: 17002922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience.
    De Gobbi M; D'Antico S; Castagno F; Testa D; Merlini R; Bondi A; Camaschella C
    Haematologica; 2004 Oct; 89(10):1161-7. PubMed ID: 15477198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemochromatosis gene C282Y homozygotes in an elderly male population.
    Willis G; Wimperis JZ; Smith KC; Fellows IW; Jennings BA
    Lancet; 1999 Jul; 354(9174):221-2. PubMed ID: 10421310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Primary hemochromatosis with abnormally low serum ferritin].
    Vázquez Romero M; Boixeda de Miquel D; Vallcorba Gómez del Valle I; Foruny Olcina JR; Valer López-Fando MP; San Román Cos-Gayón C
    Gastroenterol Hepatol; 2003; 26(6):396-7. PubMed ID: 12809577
    [No Abstract]   [Full Text] [Related]  

  • 31. A population-based study of the effect of the HFE C282Y and H63D mutations on iron metabolism.
    Njajou OT; Houwing-Duistermaat JJ; Osborne RH; Vaessen N; Vergeer J; Heeringa J; Pols HA; Hofman A; van Duijn CM
    Eur J Hum Genet; 2003 Mar; 11(3):225-31. PubMed ID: 12673276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis.
    Crawford DH; Murphy TL; Ramm LE; Fletcher LM; Clouston AD; Anderson GJ; Subramaniam VN; Powell LW; Ramm GA
    Hepatology; 2009 Feb; 49(2):418-25. PubMed ID: 19177571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Helicobacter pylori infection and HFE hemochromatosis.
    Beutler E; Gelbart T
    Blood Cells Mol Dis; 2006; 37(3):188-91. PubMed ID: 16996754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pediatric Ferroportin Disease.
    Galicia-Poblet G; Cid-París E; López-Andrés N; Losada-Pajares A; Jurado-López JC; Moreno-Carralero MI; Morán-Jiménez MJ
    J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):e205-e207. PubMed ID: 25742196
    [No Abstract]   [Full Text] [Related]  

  • 35. Metals and the liver.
    Maxwell KL; Kowdley KV
    Curr Opin Gastroenterol; 2012 May; 28(3):217-22. PubMed ID: 22395570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated MCP-1 serum levels are associated with the H63D mutation and not the C282Y mutation in hereditary hemochromatosis.
    Lawless MW; White M; Mankan AK; O'Dwyer MJ; Norris S
    Tissue Antigens; 2007 Oct; 70(4):294-300. PubMed ID: 17767550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for iron overload and HFE mutations in a university hospital.
    Remacha AF; Carrasco M; Sardà MP; Barceló MJ; Blesa I; Baiget M
    Haematologica; 2000 Aug; 85(8):873-4. PubMed ID: 10942939
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease.
    Valenti L; Swinkels DW; Burdick L; Dongiovanni P; Tjalsma H; Motta BM; Bertelli C; Fatta E; Bignamini D; Rametta R; Fargion S; Fracanzani AL
    Nutr Metab Cardiovasc Dis; 2011 Aug; 21(8):568-75. PubMed ID: 20392616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for hemochromatosis.
    Crawford DH; Hickman P
    Hepatology; 2000 May; 31(5):1192-3. PubMed ID: 10796897
    [No Abstract]   [Full Text] [Related]  

  • 40. Hereditary hemochromatosis and its elusive natural history.
    McDonnell SM; Parrish RG
    Arch Intern Med; 2003 Nov; 163(20):2421-3; author reply 2427. PubMed ID: 14609775
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.